Related Experiment Video
Updated: Feb 5, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Atrial Fibrillation and Deterioration in Cognitive Function
Insights
Atrial fibrillation is linked to cognitive decline and dementia. Treatments for atrial fibrillation, like anticoagulation and ablation, may reduce the risk of cognitive impairment, offering hope for prevention.
Area of Science:
- Cardiology
- Neurology
- Geriatrics
Background:
- Growing interest in the association between atrial fibrillation (AF) and cognitive decline/dementia.
- No definitive cure exists for cognitive decline and dementia, driving research into preventative strategies.
- The precise causal mechanisms linking AF to cognitive impairment remain incompletely understood.
Purpose of the Study:
- To review epidemiologic studies on the association between atrial fibrillation and cognitive function.
- To explore potential pathophysiological mechanisms underlying this link.
- To evaluate the impact of atrial fibrillation therapies on cognitive outcomes.
Main Methods:
- Systematic review of epidemiologic research.
- Analysis of proposed pathophysiological pathways.
- Assessment of evidence regarding therapeutic interventions for atrial fibrillation.
Main Results:
- Epidemiologic data suggest a significant association between atrial fibrillation and increased risk of cognitive decline and dementia.
- Several mechanisms, including cerebral microemboli, hypoperfusion, and inflammation, are implicated.
- Therapies for atrial fibrillation, such as anticoagulation and catheter ablation, show promise in mitigating cognitive decline.
Conclusions:
- Atrial fibrillation is a significant risk factor for cognitive decline and dementia.
- Understanding the underlying mechanisms is crucial for developing targeted preventative strategies.
- Current treatments for atrial fibrillation may offer a viable approach to preserving cognitive function.
Abstract:
The link between atrial fibrillation and cognitive decline and dementia has gained interest of the medical community lately. More research is being conducted to prevent and or delay this morbidity as no curative therapy is available for cognitive decline and dementia. The exact mechanism of causation is unclear. Multiple pathophysiological mechanisms have been implicated. Lately, treatment for atrial fibrillation including anticoagulation and catheter ablation therapies have shown to decrease the risk of deterioration of cognitive function. In this review we summarize epidemiologic studies linking the association, potential mechanisms, and impact of various modalities of therapy of atrial fibrillation on cognitive function outcomes.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Mortar Joint Deterioration in Masonry
The...
Cognitive Dissonance
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Cognition and Behavior

